https://www.selleckchem.com/products/myci975.html
18±4.7mm vs. 3.33±4.3mm (p=0.51 for the lateral head of the eyebrow, respectively. Incorporating anatomic concepts into clinical practice for glabellar frown line neuromodulator treatments with the investigated 3-point injection technique resulted in the absence of adverse events like eyebrow ptosis, upper eyelid ptosis, medial eyebrow ptosis, and lateral frontalis hyperactivity. This technique demonstrated efficacy throughout the 4-month study period. Incorporating anatomic concepts into clinical practice for glabellar frown line neu
Like
Comment
Share
